SenesTech Announces 2021 Closing Monetary and Operating Results
SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), (www. senestech. com), rodent fertility experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced that 2021 profit has more than doubled from last year as the company accelerates its penetration into existing markets and expands into a number of new vertical markets.
SenesTech Announces 2021 Closing Monetary and Operating Results Read More »